AzarGen Biotechnologies
OperatingAzarGen is a biotech company focused on developing human therapeutic proteins using advanced genetic engineering & synthetic biology
- Biotechnology
- Stellenbosch, South Africa
- Series B
- Founded 2009
- azargen.com ↗
- Total raised
- $3.1M
- disclosed
- Last round
- $3.1M
- Series B
- Rounds
- 1
- since 2009
- Employees
- 1-10
AzarGen Biotechnologies funding and investors
AzarGen Biotechnologies has raised $3.1M across 1 disclosed round. The latest is a $3.1M Series B announced 07 Jan 2016.
- Largest round
- $3.1M
AzarGen Biotechnologies funding rounds1 · newest first
- Series B$3.1M
07 Jan 2016
| Announced | Round | Lead · other investors | Amount |
|---|---|---|---|
| 07 Jan 2016 | Series B | Investors not disclosed | $3.1M |
Frequently asked about AzarGen Biotechnologies
- How much funding has AzarGen Biotechnologies raised?
- AzarGen Biotechnologies has raised $3.1M across 1 disclosed round. Its latest, a $3.1M Series B, was announced on Jan 07, 2016.
Profile updated Source: SLA Startup IndexHow we count →
